-Michael S Diamond Researcher Activity Profile

Research Author Detailed Information 

Michael S Diamond Publication Rate By Year

Michael S Diamond has published 7 paper(s) in 2006, 22 paper(s) in 2007, 5 paper(s) in 2008, for a total of 34 research publications in total.

Michael S Ms Diamond Author Information

LAST NAME: diamond

FIRST NAME: Michael S

INITIALS: ms

AFFILIATION:

Papers

Michael S Diamond's Publication Record

1. Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. Year Published: 2006
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322-4700, USA. jmorrey@cc.usu.edu
2. Crystal structure of the West Nile virus envelope glycoprotein. Year Published: 2006
Department of Pathology & Immunology, Washington University School of Medicine, Campus Box 8118, 660 South Euclid Avenue, St. Louis, MO 63110-1093, USA.
3. Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. Year Published: 2006
Department of Pathology and Immunology, Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
4. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. Year Published: 2006
Department of Medicine, Washington University School of Medicine, 660 South Euclid Ave., Box 8051, Saint Louis, MO 63110, USA.
5. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. Year Published: 2006
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Campus Box 8051, 660 S. Euclid Ave., St. Louis, MO 63110, USA.
6. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Year Published: 2006
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
7. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. Year Published: 2007
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Campus Box 8051, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
8. The molecular basis of antibody-mediated neutralization of West Nile virus. Year Published: 2007
Washington University School of Medicine, Department of Molecular Microbiology, Saint Louis, MO 63110, USA.
9. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Year Published: 2007
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA.
10. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. Year Published: 2007
Department of Medicine, Washington University School of Medicine, St. Louis. Missouri, United States of America.
11. Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model. Year Published: 2007
Institute for Antiviral Research, Animal, Dairy, and Veterinary Sciences Department, Utah State University, 4700 Old Main Hill, Logan, UT 84322-4700, USA. jmorrey@cc.usu.edu
12. Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells. Year Published: 2007
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
13. CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis. Year Published: 2007
Department of Molecular Microbiology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
14. Identification of novel small-molecule inhibitors of West Nile virus infection. Year Published: 2007
Apath, LLC, St. Louis, MO 63110, USA.
15. Induction of epitope-specific neutralizing antibodies against West Nile virus. Year Published: 2007
Departments of Medicine, Molecular Microbiology, and Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
16. Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system. Year Published: 2007
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
17. Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Year Published: 2007
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
18. The molecular basis of antibody protection against West Nile virus. Year Published: 2007
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St. Louis, MO 63110, USA.
19. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Year Published: 2007
Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institutes of Health, Bethesda, MD 20892, USA. piersontc@mail.nih.gov
20. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. Year Published: 2007
Department of Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, USA.
21. Secreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E. Year Published: 2007
22. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. Year Published: 2007
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
23. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Year Published: 2007
Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institutes of Health, Bethesda, MD 20892, USA. piersontc@mail.nih.gov
24. Complement protein c1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Year Published: 2007
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
25. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Year Published: 2007
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
26. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. Year Published: 2007
Department of Medicine, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, USA.
27. Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice. Year Published: 2008
Department of Medicine, Washington University School of Medicine, St Louis, Missouri.
28. Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. Year Published: 2006
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322-4700, USA. jmorrey@cc.usu.edu
29. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. Year Published: 2007
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
30. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Year Published: 2007
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
31. CXCR3 Mediates Region-Specific Antiviral T Cell Trafficking within the Central Nervous System during West Nile Virus Encephalitis. Year Published: 2008
Division of Infectious Diseases.
32. The relative contribution of antibody and CD8(+) T cells to vaccine immunity against West Nile encephalitis virus. Year Published: 2008
Department of Medicine, 660 S. Euclid Avenue, Box 8051, Washington University School of Medicine, St. Louis, MO 63110, United States.
33. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Year Published: 2008
Department of Biological Sciences, Purdue University, 915 West State Street, West Lafayette, Indiana 47907-2054, USA.
34. Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice. Year Published: 2008
Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA.